Lumpectomy Sets High Bar For Thermal Ablation Clinical Trials – Panel
This article was originally published in The Gray Sheet
Executive Summary
Interstitial laser therapy developer Kelsey, Inc. is urging FDA to allow the firm to combine its feasibility and pivotal trial phases in conducting research to support a breast cancer treatment indication